Cargando…
Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)
The causative agent of Severe Acute Respiratory Syndrome (SARS) was identified as a coronavirus (CoV) following the outbreak of 2002–2003. There are currently no licensed vaccines or treatments for SARS-CoV infections. Potential prevention and control strategies that show promise in vitro must be ev...
Autores principales: | Vogel, Leatrice N., Roberts, Anjeanette, Paddock, Christopher D., Genrich, Gillian L., Lamirande, Elaine W., Kapadia, Sagar U., Rose, John K., Zaki, Sherif R., Subbarao, Kanta |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847333/ https://www.ncbi.nlm.nih.gov/pubmed/17227689 http://dx.doi.org/10.1016/j.vaccine.2006.11.055 |
Ejemplares similares
-
Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
por: Kapadia, Sagar U., et al.
Publicado: (2005) -
A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice
por: Roberts, Anjeanette, et al.
Publicado: (2007) -
Animal models and vaccines for SARS-CoV infection
por: Roberts, Anjeanette, et al.
Publicado: (2008) -
Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein
por: Bisht, Himani, et al.
Publicado: (2005) -
Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys
por: McAuliffe, Josephine, et al.
Publicado: (2004)